Assertio (ASRT) 2025 Earnings: What Investors Watch
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
Assess which retirement index fund offers the best expense ratio, balancing cost with diversification and tracking accuracy.
28,154 articlesAs Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
A once-sacrosanct pledge to never dump bitcoin treasury holdings is showing cracks as firms explore selling slices to...
Strategy unveiled a plan to repurchase roughly $1.5 billion of its 2029 notes, with funding options including Bitcoin...
Salesforce unveiled a record $25 billion accelerated share repurchase funded by debt as it posted quarterly results. ...
When prominent athletes face controversy, the financial implications go beyond contracts. This piece explores how Adr...
Berkshire Hathaway is positioned to become a much larger Alphabet holder as the tech giant pursues a bold AI financin...
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
When the world's biggest ethereum treasury buys the dip, it grabs headlines—and raises questions for everyday investo...
Retirees are increasingly aiming for dependable cash flow without depleting principal. A $850,000 portfolio that quie...
Investors often chase big biotech gains, but Viking Therapeutics stock really hinges on milestones and cash runway. T...
BlackRock’s IBIT drew about $209 million in a single session, helping U.S. spot Bitcoin ETFs turn positive again. Mar...